A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61P 1/02 (2006.01)
Patent
CA 2643736
Methods and compositions of AMP- 18 derived peptides enablingly demonstrate that AMP-18 derived peptide compositions surprisingly reduce mucositis in mammals. Methods and peptide compositions treat mucositis, delays the onset or duration of mucositis, including cancer therapy-induced mucositis are disclosed. AMP 77-97 peptide derived from human AMP-18 protein alleviates cancer therapy-induced mucositis.
La présente invention concerne des procédés et des compositions à base de peptides dérivés d'AMP-18, qui font la preuve de façon validante que les compositions à base de peptides dérivés d'AMP-18 atténuent de façon surprenante la mucosite chez les mammifères. L'invention concerne notamment des procédés et des compositions qui traitent la mucosite, qui retardent la survenue ou la durée de la mucosite, y-compris les mucosites induites par les thérapies anticancéreuses. Les peptides AMP 77-97 dérivés de la protéine AMP-18 humaine atténuent les mucosites induites par les thérapies anticancéreuses.
The University Of Chicago
Torys Llp
LandOfFree
Use of peptides derived from the growth factor amp-18 for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of peptides derived from the growth factor amp-18 for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of peptides derived from the growth factor amp-18 for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1828249